The impact of COVID-19 disruption to cervical cancer screening in England on excess diagnoses
View ORCID ProfileAlejandra Castanon, View ORCID ProfileRebolj M Matejka, View ORCID ProfileFrancesca Pesola, View ORCID ProfilePeter Sasieni
doi: https://doi.org/10.1101/2020.11.30.20240754
Alejandra Castanon
1King’s College London, Faculty of Life Sciences & Medicine, School of Cancer & Pharmaceutical Sciences
Rebolj M Matejka
1King’s College London, Faculty of Life Sciences & Medicine, School of Cancer & Pharmaceutical Sciences
Francesca Pesola
1King’s College London, Faculty of Life Sciences & Medicine, School of Cancer & Pharmaceutical Sciences
Peter Sasieni
1King’s College London, Faculty of Life Sciences & Medicine, School of Cancer & Pharmaceutical Sciences
Posted November 30, 2020.
The impact of COVID-19 disruption to cervical cancer screening in England on excess diagnoses
Alejandra Castanon, Rebolj M Matejka, Francesca Pesola, Peter Sasieni
medRxiv 2020.11.30.20240754; doi: https://doi.org/10.1101/2020.11.30.20240754
Subject Area
Subject Areas
- Addiction Medicine (381)
- Allergy and Immunology (699)
- Anesthesia (189)
- Cardiovascular Medicine (2832)
- Dermatology (242)
- Emergency Medicine (427)
- Epidemiology (12531)
- Forensic Medicine (10)
- Gastroenterology (800)
- Genetic and Genomic Medicine (4409)
- Geriatric Medicine (400)
- Health Economics (712)
- Health Informatics (2838)
- Health Policy (1045)
- Hematology (373)
- HIV/AIDS (893)
- Medical Education (412)
- Medical Ethics (114)
- Nephrology (460)
- Neurology (4167)
- Nursing (220)
- Nutrition (615)
- Oncology (2194)
- Ophthalmology (623)
- Orthopedics (254)
- Otolaryngology (316)
- Pain Medicine (265)
- Palliative Medicine (81)
- Pathology (485)
- Pediatrics (1169)
- Primary Care Research (481)
- Public and Global Health (6752)
- Radiology and Imaging (1484)
- Respiratory Medicine (897)
- Rheumatology (430)
- Sports Medicine (365)
- Surgery (471)
- Toxicology (57)
- Transplantation (200)
- Urology (173)